|
|
Gene Symbol |
STAT3 |
|
Aliases |
ADMIO, ADMIO1, APRF, HIES |
|
Entrez Gene ID |
|
|
Gene Name |
Signal transducer and activator of transcription 3 |
|
Chromosomal Location |
17q21.2 |
|
HGNC ID |
|
|
Summary |
The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is activated through phosphorylation in response to various cytokines and growth factors including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2. This protein mediates the expression of a variety of genes in response to cell stimuli, and thus plays a key role in many cellular processes such as cell growth and apoptosis. The small GTPase Rac1 has been shown to bind and regulate the activity of this protein. PIAS3 protein is a specific inhibitor of this protein. Mutations in this gene are associated with infantile-onset multisystem autoimmune disease and hyper-immunoglobulin E syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Sep 2015]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
NM_003150.4, NM_213662.2, NM_001369512.1, NM_001369513.1, NM_001369514.1, NM_001369516.1, NM_001369517.1, NM_001369518.1, NM_001369519.1, NM_001369520.1, NM_139276.2 |
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0000122 |
Biological process |
Negative regulation of transcription by RNA polymerase II |
TAS |
8675499 |
GO:0006355 |
Biological process |
Regulation of transcription, DNA-templated |
IDA |
15664994, 17344214 |
GO:0006606 |
Biological process |
Protein import into nucleus |
IDA |
18234692 |
GO:0006952 |
Biological process |
Defense response |
IBA |
21873635 |
GO:0007165 |
Biological process |
Signal transduction |
TAS |
7512451, 10205054 |
GO:0007259 |
Biological process |
JAK-STAT cascade |
IBA |
21873635 |
GO:0007259 |
Biological process |
JAK-STAT cascade |
TAS |
15664994 |
GO:0007399 |
Biological process |
Nervous system development |
TAS |
10205054 |
GO:0010507 |
Biological process |
Negative regulation of autophagy |
IDA |
26962683 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IDA |
23820254 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IMP |
24255059 |
GO:0019221 |
Biological process |
Cytokine-mediated signaling pathway |
IBA |
21873635 |
GO:0019221 |
Biological process |
Cytokine-mediated signaling pathway |
NAS |
15664994 |
GO:0030335 |
Biological process |
Positive regulation of cell migration |
IMP |
24846175 |
GO:0030522 |
Biological process |
Intracellular receptor signaling pathway |
IDA |
17324931 |
GO:0032355 |
Biological process |
Response to estradiol |
IDA |
12552091 |
GO:0032870 |
Biological process |
Cellular response to hormone stimulus |
IDA |
12552091 |
GO:0033210 |
Biological process |
Leptin-mediated signaling pathway |
IBA |
21873635 |
GO:0033210 |
Biological process |
Leptin-mediated signaling pathway |
IDA |
17344214 |
GO:0035278 |
Biological process |
MiRNA mediated inhibition of translation |
IDA |
23820254 |
GO:0042127 |
Biological process |
Regulation of cell proliferation |
IBA |
21873635 |
GO:0043066 |
Biological process |
Negative regulation of apoptotic process |
IMP |
22984561 |
GO:0043434 |
Biological process |
Response to peptide hormone |
IBA |
21873635 |
GO:0044320 |
Biological process |
Cellular response to leptin stimulus |
IDA |
17344214 |
GO:0044321 |
Biological process |
Response to leptin |
IDA |
17344214 |
GO:0045648 |
Biological process |
Positive regulation of erythrocyte differentiation |
IMP |
28283061 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IDA |
19390056 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IMP |
23066027 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IDA |
17324931 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IGI |
19754877, 24429361 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IMP |
16835372, 16946298 |
GO:0051726 |
Biological process |
Regulation of cell cycle |
IDA |
17344214 |
GO:0060396 |
Biological process |
Growth hormone receptor signaling pathway |
IDA |
10925297 |
GO:0060397 |
Biological process |
JAK-STAT cascade involved in growth hormone signaling pathway |
IBA |
21873635 |
GO:0060397 |
Biological process |
JAK-STAT cascade involved in growth hormone signaling pathway |
IDA |
12552091 |
GO:0070102 |
Biological process |
Interleukin-6-mediated signaling pathway |
IDA |
12359225, 12552091, 17324931, 24429361 |
GO:0070102 |
Biological process |
Interleukin-6-mediated signaling pathway |
IMP |
16835372, 16946298 |
GO:1902895 |
Biological process |
Positive regulation of pri-miRNA transcription by RNA polymerase II |
IDA |
19390056, 23820254 |
GO:1904685 |
Biological process |
Positive regulation of metalloendopeptidase activity |
IGI |
23820254 |
GO:2000637 |
Biological process |
Positive regulation of gene silencing by miRNA |
IDA |
23820254 |
GO:0000790 |
Cellular component |
Nuclear chromatin |
IDA |
16835372 |
GO:0005634 |
Cellular component |
Nucleus |
IBA |
21873635 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
10336453, 12444102, 17324931, 17360477, 18234692, 22783022, 24846175, 28065600 |
GO:0005667 |
Cellular component |
Transcription factor complex |
IDA |
24429361 |
GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
17360477, 18234692, 22783022 |
GO:0005829 |
Cellular component |
Cytosol |
IBA |
21873635 |
GO:0090575 |
Cellular component |
RNA polymerase II transcription factor complex |
IC |
16835372 |
GO:0090575 |
Cellular component |
RNA polymerase II transcription factor complex |
IMP |
16946298 |
GO:0000978 |
Molecular function |
RNA polymerase II proximal promoter sequence-specific DNA binding |
IBA |
21873635 |
GO:0000978 |
Molecular function |
RNA polymerase II proximal promoter sequence-specific DNA binding |
IDA |
19390056 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISM |
19274049 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
NAS |
19274049 |
GO:0001103 |
Molecular function |
RNA polymerase II repressing transcription factor binding |
IPI |
22783022 |
GO:0001228 |
Molecular function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
IBA |
21873635 |
GO:0001228 |
Molecular function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
IDA |
16835372 |
GO:0001228 |
Molecular function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
IMP |
16946298 |
GO:0003700 |
Molecular function |
DNA-binding transcription factor activity |
IDA |
17344214 |
GO:0004879 |
Molecular function |
Nuclear receptor activity |
IDA |
17324931 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
8662591, 9864141, 10688651, 11536047, 11585385, 11940572, 11970898, 12867595, 14966128, 15286705, 15657067, 15764709, 15821101, 15998644, 16273093, 16306601, 16331268, 16364321, 16531398, 16568091, 18200042, 18234692, 18330356, 19345327, 19372587, 20133729, 20826784, 20871632, 20876 |
GO:0008134 |
Molecular function |
Transcription factor binding |
IPI |
15664994, 24429361 |
GO:0019903 |
Molecular function |
Protein phosphatase binding |
IPI |
12359225, 17360477 |
GO:0031490 |
Molecular function |
Chromatin DNA binding |
IDA |
17344214 |
GO:0042802 |
Molecular function |
Identical protein binding |
IPI |
7510216, 17676033, 21988832, 25609649 |
GO:0044212 |
Molecular function |
Transcription regulatory region DNA binding |
IDA |
17324931 |
|
Protein Information |
|
Protein Name |
Signal transducer and activator of transcription 3, DNA-binding protein APRF, acute-phase response factor |
|
Function |
Signal transducer and transcription activator that mediates cellular responses to interleukins, KITLG/SCF, LEP and other growth factors. Once activated, recruits coactivators, such as NCOA1 or MED1, to the promoter region of the target gene (PubMed:17344214). May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4 (PubMed:12873986). Binds to the interleukin-6 (IL-6)-responsive elements identified in the promoters of various acute-phase protein genes. Activated by IL31 through IL31RA. Acts as a regulator of inflammatory response by regulating differentiation of naive CD4(+) T-cells into T-helper Th17 or regulatory T-cells (Treg): deacetylation and oxidation of lysine residues by LOXL3, leads to disrupt STAT3 dimerization and inhibit its transcription activity. Involved in cell cycle regulation by inducing the expression of key genes for the progression from G1 to S phase, such as CCND1 (PubMed:17344214). Mediates the effects of LEP on melanocortin production, body energy homeostasis and lactation (By similarity). May play an apoptotic role by transctivating BIRC5 expression under LEP activation (PubMed:18242580). Cytoplasmic STAT3 represses macroautophagy by inhibiting EIF2AK2/PKR activity (PubMed:23084476). Plays a crucial role in basal beta cell functions, such as regulation of insulin secretion (By similarity). |
|
|
|
NP_003141.2, NP_998827.1, NP_001356441.1, NP_001356442.1, NP_001356443.1, NP_001356445.1, NP_001356446.1, NP_001356447.1, NP_001356448.1, NP_001356449.1, NP_644805.1
|
|
UniProt |
|
|
PDB |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000263640 |
Q04771 |
Q04771 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Cardiomyopathy |
|
Atherosclerosis |
|
Myocardial Diseases |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Genetic Diseases |
18602572, 20159255, 25359994, 17881745, 22751495, 28073828, 26394394, 26343524, 22520845, 29180260, 25038750 |
Craniosynostosis |
|
Congenital diaphragmatic hernia |
|
Digestive System Diseases |
Inflammatory Bowel Diseases |
|
Crohn Disease |
|
Colitis |
|
Chronic hepatitis |
|
Cholangitis |
|
Liver Cirrhosis |
|
Ear Or Mastoid Diseases |
Meniere Disease |
|
Endocrine System Diseases |
Ketosis-prone diabetes |
|
Diabetes Mellitus |
|
Brittle diabetes |
|
PCOS |
|
Immune System Diseases |
Hyperimmunoglobulin E syndrome |
17881745, 17676033, 26293184, 23342295, 20159255, 21792878, 18602572, 20032313, 27226025, 20816194, 18706697, 27980540, 18978467, 25038750, 26384563, 28492532, 17942886, 22030463, 25359994, 20301786, 29077208, 4161105, 27799162 |
Autoimmune Diseases |
|
Juvenile arthritis |
|
Still Disease |
|
Autoimmune Diabetes |
|
Musculoskeletal Diseases |
Spondylitis |
|
Neoplasms |
Adenocarcinoma |
|
Lung Cancer |
|
Carcinoma |
|
Multiple Sclerosis |
|
Medulloblastoma |
|
Leukemia |
|
Head Neoplasms |
|
Stomach Cancer |
|
Prostate cancer |
|
Ovarian Cancer |
|
Pancreatic Neoplasm |
|
Anaplastic Carcinoma |
|
Endometrial Cancer |
|
Liver Cancer |
|
Lymphoma |
|
Breast Cancer |
|
Cancer Metastasis |
|
Cervical Cancer |
|
Myeloid Leukemia |
|
Colonic Neoplasms |
|
Cribriform Carcinoma |
|
Gastric Cancer |
|
Nervous System Diseases |
Cerebral Ischemia |
|
Cerebral Artery Infarction |
|
Brain Infarction |
|
Middle Cerebral Artery Syndrome |
|
Cerebral Thrombosis |
|
Psychiatric/Brain disorders |
Memory Disorders |
|
Mental Depression |
|
Respiratory Tract Diseases |
Asthma |
|
Skin and Connective Tissue Diseases |
Dermatitis |
|
Psoriasis |
|
Pustulosis |
|
|
References |
|
|
Li Mei-Gen, Ding Guo-Lian, Chen Xi-Jing, Lu Xi-Ping, Dong Li-Jun, Dong Min-Yue, Yang Xiao-Fu, Lu Xiu-E, Huang He-Feng |
Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, 2 Xue Shi Road, Hangzhou, Zhejiang, 31006, China. |
J Clin Endocrinol Metab. 2007 Dec;92(12):4771-6. doi: 10.1210/jc.2007-0978. Epub |
Abstract
OBJECTIVE: Our objective was to evaluate whether polycystic ovarian syndrome (PCOS)-associated infertility is related to alterations of leptin, leptin receptor (Ob-R), and the phosphorylated signal transducer and activator of transcription 3 (p-STAT3)/suppressor of cytokine signal 3 (SOCS3) system in the ovary. DESIGN AND SETTING: A case-control study was conducted in a university hospital. PATIENTS: Thirty-one infertile PCOS women with oligoovulation plus polycystic ovarian morphology and 79 infertile women with tubal blockage (control) participated in the study. The subjects were stratified according to in vitro fertilization outcomes: successful and failed subgroups. METHODS: Serum and follicular fluid (FF) leptin levels were measured with ELISA. RT-PCR and Western blotting were performed to assess expression of mRNA encoding leptin and Ob-R and proteins of p-STAT3 and SOCS3 in granulosa cells (GCs). RESULTS: Leptin levels in serum and FF of PCOS women were significantly higher than those of control (P < 0.01). There were no significant differences in expression of leptin mRNA and short and long Ob-Rs between PCOS and control (P > 0.05). The p-STAT3 level was decreased in PCOS compared with control (P < 0.01), whereas SOCS3 remained significantly unchanged (P > 0.05). Further analysis showed that serum and FF leptin levels were significantly higher, whereas p-STAT3 in GCs was lower in the failed subgroup of PCOS than those in the successful subgroup of PCOS (P < 0.05). CONCLUSION: Hyperleptinemia and high FF leptin are important pathologies of PCOS with infertility. Lower levels of p-STAT3 in GCs may be related to ovarian leptin resistance and fecundity in PCOS women. Relatively high serum and FF leptin and low p-STAT3 in GCs may account for decreased fertilization, implantation, and pregnancy rates of in vitro fertilization in PCOS women. |
|
|
|
|
| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412
|